Rare diseases
Investigational molecules
Locations
Back to Italy246 clinical trials in Reggio Emilia, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Phase 2 Study of Nemolizumab for Skin Thickening in Adults with Systemic Sclerosis
ItalyPhase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
ItalyStudy of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)
ItalyA study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time
ItalyStudy of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing
ItalyStudy on IPN10200 for Treating Cervical Dystonia in Adults
ItalyStudy of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer
ItalyA Study of Setidegrasib with Chemotherapy Drug Combination as First‑Line Treatment in Adults with KRAS G12D‑mutated Metastatic Pancreatic Cancer
ItalyStudy of precemtabart tocentecan alone or in drug combination versus standard therapy in previously treated metastatic colorectal cancer patients
ItalyEfficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial
ItalyRinatabart Sesutecan plus bevacizumab vs standard care as maintenance for recurrent platinum‑sensitive ovarian cancer after second‑line chemotherapy
ItalyStudy of MK-1045 alone or with tocilizumab in patients with Non‑Hodgkin Lymphoma to evaluate safety and efficacy
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on metastatic colorectal cancer, non-small cell lung cancer, and gastric cancer. Research evaluates novel therapeutic approaches including targeted therapies and immunotherapy combinations.
Studies include assessment of treatment efficacy and novel drug combinations for advanced stage cancers.
Groundbreaking research in B-cell lymphomas and chronic myeloid leukemia. Studies evaluate innovative treatment approaches including targeted therapies and combination protocols.
Focus on improving patient outcomes through personalized treatment approaches.
Clinical trials investigating treatments for Sjögren's Syndrome and other inflammatory conditions. Research aims to evaluate long-term safety and efficacy of novel therapeutic agents.
Studies focus on developing safer and more effective treatment options for patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
